{"transactions":[{"id":686878,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":23328,"kind":"person","name":"SCHMITT DANIEL M","position":1,"cik":"0001318470","reported_name":"SCHMITT DANIEL M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Restricted Stock Units","published_at":"2026-08-14T21:00:03.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":false,"shares":272056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"544,111 restricted stock units were granted upon the closing of the issuer's initial public offering on August 14, 2024, of which, 272,055 vested on August 14, 2025 (and settled on February 13, 2026) and 272,056 vested on August 14, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"544,111 restricted stock units were granted upon the closing of the issuer's initial public offering on August 14, 2024, of which, 272,055 vested on August 14, 2025 (and settled on February 13, 2026) and 272,056 vested on August 14, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":272056},"source":{"system":"sec-edgar","filing":"0001683168-26-006493","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316826006493/ownership.xml","form_type":"4"}},{"id":686877,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":23328,"kind":"person","name":"SCHMITT DANIEL M","position":1,"cik":"0001318470","reported_name":"SCHMITT DANIEL M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Common Stock","published_at":"2026-08-14T21:00:03.000Z","date":"2026-08-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":120521,"price":1.01,"value":121726.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 120,521 shares of common stock withheld by Issuer to satisfy federal and state withholding taxes owed by holder upon the settlement of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of Issuer's common stock on August 14, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents 120,521 shares of common stock withheld by Issuer to satisfy federal and state withholding taxes owed by holder upon the settlement of restricted stock units (\"RSUs\")."}],"balance_after":301716,"source":{"system":"sec-edgar","filing":"0001683168-26-006493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316826006493/ownership.xml","form_type":"4"}},{"id":686876,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":23328,"kind":"person","name":"SCHMITT DANIEL M","position":1,"cik":"0001318470","reported_name":"SCHMITT DANIEL M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Common Stock","published_at":"2026-08-14T21:00:03.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":true,"shares":272056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the issuance of 272,056 shares of common stock from the vesting and settlement of 272,056 RSUs, which number excludes the withholding of 120,521 shares by Issuer to satisfy federal and state withholding taxes due at settlement (see Note 1)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the issuance of 272,056 shares of common stock from the vesting and settlement of 272,056 RSUs, which number excludes the withholding of 120,521 shares by Issuer to satisfy federal and state withholding taxes due at settlement (see Note 1)."}],"balance_after":422237,"source":{"system":"sec-edgar","filing":"0001683168-26-006493","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316826006493/ownership.xml","form_type":"4"}},{"id":822843,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":23328,"kind":"person","name":"SCHMITT DANIEL M","position":1,"cik":"0001318470","reported_name":"SCHMITT DANIEL M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-04-01T21:19:52.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":237000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will vest as to 25% on April 1, 2027 with the remaining 75% vesting in equal monthly installments during the 36 months following the first anniversary of the grant date."}],"balance_after":237000,"derivative":{"exercise_price":2.49,"expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":237000},"source":{"system":"sec-edgar","filing":"0001683168-26-002582","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316826002582/ownership.xml","form_type":"4"}},{"id":905194,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":23328,"kind":"person","name":"SCHMITT DANIEL M","position":1,"cik":"0001318470","reported_name":"SCHMITT DANIEL M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Restricted Stock Units","published_at":"2026-02-13T23:10:04.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":false,"shares":272055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"544,111 restricted stock units were granted upon the closing of the issuer's initial public offering on August 14, 2024, of which, 272,055 vested on August 14, 2025 (and settled on February 13, 2026) and 272,056 vest on August 14, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"544,111 restricted stock units were granted upon the closing of the issuer's initial public offering on August 14, 2024, of which, 272,055 vested on August 14, 2025 (and settled on February 13, 2026) and 272,056 vest on August 14, 2026."}],"balance_after":272056,"derivative":{"underlying":"Common Stock","underlying_shares":272055},"source":{"system":"sec-edgar","filing":"0001683168-26-001039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316826001039/ownership.xml","form_type":"4"}},{"id":905193,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":23328,"kind":"person","name":"SCHMITT DANIEL M","position":1,"cik":"0001318470","reported_name":"SCHMITT DANIEL M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Common Stock","published_at":"2026-02-13T23:10:04.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":121874,"price":4.33,"value":527714.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 121,874 shares of common stock withheld by Issuer to satisfy federal and state withholding taxes owed by holder upon the settlement of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the closing price of Issuer's common stock on February 13, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents 121,874 shares of common stock withheld by Issuer to satisfy federal and state withholding taxes owed by holder upon the settlement of restricted stock units (\"RSUs\")."}],"balance_after":150181,"source":{"system":"sec-edgar","filing":"0001683168-26-001039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316826001039/ownership.xml","form_type":"4"}},{"id":905192,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":23328,"kind":"person","name":"SCHMITT DANIEL M","position":1,"cik":"0001318470","reported_name":"SCHMITT DANIEL M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Common Stock","published_at":"2026-02-13T23:10:04.000Z","date":"2026-02-13","kind":"exercise","planned":false,"acquired":true,"shares":272055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the issuance of 272,055 shares of common stock from the vesting and settlement of 272,055 RSUs, which number excludes the withholding of 121,874 shares by Issuer to satisfy federal and state withholding taxes due at settlement (see Note 1)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents the issuance of 272,055 shares of common stock from the vesting and settlement of 272,055 RSUs, which number excludes the withholding of 121,874 shares by Issuer to satisfy federal and state withholding taxes due at settlement (see Note 1)."}],"balance_after":272055,"source":{"system":"sec-edgar","filing":"0001683168-26-001039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316826001039/ownership.xml","form_type":"4"}},{"id":1183406,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":23328,"kind":"person","name":"SCHMITT DANIEL M","position":1,"cik":"0001318470","reported_name":"SCHMITT DANIEL M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-02T17:44:57.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":204285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options will vest as to 25% on August 14, 2025 with the remaining 75% vesting in equal monthly installments during the 36 months thereafter."}],"balance_after":204285,"derivative":{"exercise_price":6.7,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":204285},"source":{"system":"sec-edgar","filing":"0001683168-25-002212","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825002212/ownership.xml","form_type":"4"}},{"id":1183405,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":23328,"kind":"person","name":"SCHMITT DANIEL M","position":1,"cik":"0001318470","reported_name":"SCHMITT DANIEL M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-02T17:44:57.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":66503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options will vest as to 25% on April 1, 2026 with the remaining 75% vesting in equal monthly installments during the 36 months following the first anniversary of the grant date."}],"balance_after":66503,"derivative":{"exercise_price":6.7,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":66503},"source":{"system":"sec-edgar","filing":"0001683168-25-002212","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825002212/ownership.xml","form_type":"4"}},{"id":1433613,"issuer":{"id":7370,"kind":"organization","name":"ACTUATE THERAPEUTICS, INC."},"owners":[{"id":23328,"kind":"person","name":"SCHMITT DANIEL M","position":1,"cik":"0001318470","reported_name":"SCHMITT DANIEL M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Director"}}],"security":"Restricted Stock Units","published_at":"2024-08-14T23:29:53.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":544111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"544,111 restricted stock units granted upon the closing of the issuer's initial public offering on August 14, 2024, 50% of which vest on the first anniversary of the closing of such transaction and 50% of which vest on the second anniversary of the closing of such transaction."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"544,111 restricted stock units granted upon the closing of the issuer's initial public offering on August 14, 2024, 50% of which vest on the first anniversary of the closing of such transaction and 50% of which vest on the second anniversary of the closing of such transaction."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":544111},"source":{"system":"sec-edgar","filing":"0001104659-24-089795","document":"tm2421559-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652935/000110465924089795/tm2421559-7_4seq1.xml","form_type":"4"}}]}